Spirudio Tablet
NDC Package 87754-0002-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Spirudio tablets is directions: Dissolve 1 tablet, three times daily under the tongue. This formulation utilizes a tablet delivery system. Marketed by Progresyvus Tyrimai Mb, this product is identified by NDC 87754-0002.

Identification & Billing

NDC Package Code
87754-0002-1
Package Description
60 U in 1 BOTTLE
Product Code
87754-0002
11-Digit Billing Format
87754000201

Clinical Specifications

Proprietary Name
Spirudio
Non-Proprietary Name
Spirudio
Substance Name
Lapine S-100 Immune Globulin
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Sublingual - Administration beneath the tongue.
Active Ingredient(s)
LAPINE S-100 IMMUNE GLOBULIN 30 [hp_C]/U
Usage Information
Directions: Dissolve 1 tablet, three times daily under the tongue. For stronger effects, up to 2 tablets, three times daily may be taken. Use regularly for best results.

Regulatory & Marketing

Labeler Name
Progresyvus Tyrimai Mb
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87754-0002-1 identifies a specific commercial package of 60 u in 1 bottle of Spirudio, a human over the counter drug labeled by Progresyvus Tyrimai Mb. This tablet is formulated for sublingual use and contains lapine s-100 immune globulin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Progresyvus Tyrimai Mb on June 01, 2026. The current certification is valid through December 31, 2027.

How is this Progresyvus Tyrimai Mb product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87754000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
87754-0002-1
11-Digit CMS (5-4-2)
87754-0002-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.